Web24 Aug 2024 · NEW YORK, Aug. 24, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL ), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system... Web29 Mar 2024 · Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet …

Seelos Therapeutics Doses the First Amyotrophic Lateral …

Web9 Aug 2024 · Seelos Business Update As of the end of Q2, Seelos had $87 .2mm of cash. It currently has no outstanding debt. In January, Seelos raised $33.5 million in net proceeds in an offering of... Web4 Apr 2024 · Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients ... malaysia beach resorts october

SEELOS THERAPEUTICS, INC. - MarketScreener.com

Web23 Aug 2024 · Seelos Therapeutics launches $6.7 million direct share offering with certain institutional investors The company intends to use the net proceeds for general corporate … Web13 Feb 2024 · Under this EAP, Seelos plans to enroll 70 patients in a 24-week, open-label study to evaluate SLS-005 in persons with ALS who do not qualify for other ongoing clinical trials, thus offering these ... Web10 Mar 2024 · Seelos plans to use the net proceeds for general corporate purposes and to develop its product candidates. The offering is expected to close by March 14. SEEL -9.27% to $0.54 premarket March 10... malaysia beauty influencer instagram